{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T04:19:12Z","timestamp":1741753152287,"version":"3.38.0"},"reference-count":56,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Womens Health (Lond Engl)"],"published-print":{"date-parts":[[2015,11]]},"abstract":"<jats:p> Odanacatib represents a novel treatment option in the approach of postmenopausal women. Postmenopausal women with osteoporosis experience a disturbance in bone remodeling wherein bone resorption exceeds bone formation. Cathepsin K is a lysosomal cysteine protease found primarily in osteoclasts that plays a major role in the breakdown of bone via its collagenase properties. Targeting a new area of pathophysiology, odanacatib inhibits cathepsin K to reduce bone resorption while preserving bone formation. Phase II and III trials have shown efficacy in increasing bone mineral density in the target treatment group. Overall, safety studies have found odanacatib to be well-tolerated and comparable to placebo; however, some imbalances in adverse events have been observed in the Phase III trials. Current and future studies will analyze the long-term ability of odanacatib in preventing bone fracture. <\/jats:p>","DOI":"10.2217\/whe.15.39","type":"journal-article","created":{"date-parts":[[2015,9,7]],"date-time":"2015-09-07T13:28:43Z","timestamp":1441632523000},"page":"805-814","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Odanacatib: An Emerging Novel Treatment Alternative for Postmenopausal Osteoporosis"],"prefix":"10.1177","volume":"11","author":[{"given":"Thomas C","family":"Schultz","sequence":"first","affiliation":[{"name":"Jefferson School of Pharmacy, Thomas Jefferson University, 901 Walnut Street, Suite 901, Philadelphia, PA 19107, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan P","family":"Valenzano","sequence":"additional","affiliation":[{"name":"Jefferson School of Pharmacy, Thomas Jefferson University, 901 Walnut Street, Suite 901, Philadelphia, PA 19107, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica L","family":"Verzella","sequence":"additional","affiliation":[{"name":"Jefferson School of Pharmacy, Thomas Jefferson University, 901 Walnut Street, Suite 901, Philadelphia, PA 19107, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena M","family":"Umland","sequence":"additional","affiliation":[{"name":"Jefferson School of Pharmacy, Thomas Jefferson University, 901 Walnut Street, Suite 901, Philadelphia, PA 19107, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2015,11,1]]},"reference":[{"key":"bibr1a-whe.15.39","unstructured":"Papers of special note have been highlighted as:"},{"key":"bibr2a-whe.15.39","unstructured":"of interest; \u2022\u2022 of considerable interest."},{"key":"bibr1-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1346.019"},{"volume-title":"Bone health and osteoporosis: a report of the Surgeon General","author":"Office of the Surgeon General (US)","key":"bibr2-whe.15.39"},{"key":"bibr3-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevEukaryotGeneExpr.v13.i1.30"},{"key":"bibr4-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-014-2794-2"},{"key":"bibr7a-whe.15.39","unstructured":"National Osteoporosis Foundation's current osteoporosis prevention and treatment guidelines."},{"key":"bibr5-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2269"},{"key":"bibr6-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1097\/gme.0b013e3181c617e6"},{"key":"bibr7-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.061113"},{"key":"bibr8-whe.15.39","unstructured":"National Committee for Quality Assurance. HEDIS & Performance Measurement. Proposed Changes to Existing Measure for HEDIS\u00ae1 2015: Osteoporosis Management in Women Who Had a Fracture (OMW). Washington, DC, USA. www.ncqa.org."},{"key":"bibr9-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2010.05666.x"},{"key":"bibr10-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-014-0237-9"},{"key":"bibr11-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0b013e3182a98295"},{"key":"bibr12-whe.15.39","first-page":"435","volume":"7","author":"Das S","year":"2013","journal-title":"Drug Des. Devel. Ther."},{"key":"bibr13-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.11.6953"},{"key":"bibr14-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2013.09.023"},{"key":"bibr15-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.253"},{"key":"bibr16-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2005.07.010"},{"key":"bibr17-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1302\/0301-620X.94B3.27999"},{"key":"bibr18-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2012.07.049"},{"key":"bibr19-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.joms.2009.01.003"},{"key":"bibr20-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2015.993278"},{"key":"bibr21-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X09352920"},{"key":"bibr22-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1592\/phco.31.5.510"},{"key":"bibr23-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60856-9"},{"key":"bibr24-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12339"},{"key":"bibr25-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.274"},{"key":"bibr26-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1517\/13543780902832661"},{"key":"bibr27-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2006.07.015"},{"key":"bibr28-whe.15.39","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S26729"},{"key":"bibr29-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2007.12.047"},{"key":"bibr30-whe.15.39","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-castrill\u00f3n JL, Pinacho F, De luis D, Lopezmenendez M, Due\u00f1as laita A. Odanacatib, a new drug for the treatment of osteoporosis: review of the results in postmenopausal women. J. Osteoporos. doi: 10.4061\/2010\/401581 (2010) (Epub ahead of print).","DOI":"10.4061\/2010\/401581"},{"key":"bibr31-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1038\/bonekey.2012.67"},{"key":"bibr32-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.113.056580"},{"key":"bibr33-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2012.04471.x"},{"key":"bibr37a-whe.15.39","unstructured":"Key Phase I clinical trial evaluating safety, tolerability characteristics and, pharmacodynamic and pharmacokinetic properties of odanacatib."},{"key":"bibr34-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.60"},{"key":"bibr35-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1688"},{"issue":"5","key":"bibr36-whe.15.39","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1359\/jbmr.091035","volume":"25","author":"Bone HG","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"bibr41a-whe.15.39","unstructured":"Key Phase II clinical trial evaluating safety and effect on bone mineral density."},{"key":"bibr37-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.212"},{"key":"bibr43a-whe.15.39","unstructured":"1-year continuation of previous reference."},{"key":"bibr38-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1695"},{"key":"bibr45a-whe.15.39","unstructured":"2-year extension of previous reference."},{"key":"bibr39-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.14.1344"},{"key":"bibr40-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-011-1773-0"},{"key":"bibr41-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.24.2927"},{"key":"bibr42-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2020"},{"key":"bibr50a-whe.15.39","unstructured":"Key Phase II study showing safety and tolerability of odanacatib and potential efficacy findings."},{"key":"bibr43-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2972"},{"key":"bibr52a-whe.15.39","unstructured":"Key Phase III clinical trial showing improvement in bone density markers and potential long-term efficacy data."},{"key":"bibr44-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-014-2944-6"},{"volume":"29","journal-title":"J. Bone Miner. Res.","author":"Recker R","key":"bibr45-whe.15.39"},{"key":"bibr55a-whe.15.39","unstructured":"Abstract from the September 2014 Annual Meeting of the American Society of Bone and Mineral Research."},{"key":"bibr46-whe.15.39","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-013-2398-2"}],"container-title":["Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.2217\/whe.15.39","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.2217\/whe.15.39","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.2217\/whe.15.39","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T05:48:17Z","timestamp":1741672097000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.2217\/whe.15.39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":56,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.2217\/whe.15.39"],"URL":"https:\/\/doi.org\/10.2217\/whe.15.39","relation":{},"ISSN":["1745-5057","1745-5065"],"issn-type":[{"type":"print","value":"1745-5057"},{"type":"electronic","value":"1745-5065"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}